{
  "id": "2908c4b397554ac7",
  "title": "STAT+: In expert panel, FDA says \u2018door is open\u2019 for testosterone labeling revisions",
  "description": "Exactly a month after it announced the removal of black box warning labels on estrogen therapy products used in menopause, the Food and Drugs Administration hosted an expert panel to&#8230;",
  "content": "Exactly a month after it announced the removal of black box warning labels on estrogen therapy products used in menopause, the Food and Drugs Administration hosted an expert panel to&#8230;",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/10/fda-panel-ease-access-testosterone-therapy-men/?utm_campaign=rss",
  "published_at": "2025-12-11T00:56:13+00:00",
  "fetched_at": "2025-12-12T00:22:56.348095+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: In expert panel, FDA says \u2018door is open\u2019 for testosterone labeling revisions",
    "description": "Exactly a month after it announced the removal of black box warning labels on estrogen therapy products used in menopause, the Food and Drugs Administration hosted an expert panel to&#8230;",
    "url": "https://www.statnews.com/2025/12/10/fda-panel-ease-access-testosterone-therapy-men/?utm_campaign=rss",
    "published": "2025-12-11T00:56:13+00:00",
    "source": "STAT"
  }
}